CIA
PFE icon

CCM Investment Advisers’s Pfizer PFE Stock Holding History

CCM Investment Advisers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,532
Closed -$217K – 77
2023
Q3 		$217K Sell
6,532
-148,229
-96% -$5.24M 0.03% 66
2023
Q2 		$5.68M Sell
154,761
-123,696
-44% -$4.81M 0.76% 56
2023
Q1 		$11.4M Buy
278,457
+140,826
+102% +$6.08M 1.61% 32
2022
Q4 		$7.05M Buy
+137,631
New +$6.6M 1.12% 51
2020
Q2 		– Sell
-15,723
Closed -$486K – 64
2020
Q1 		$486K Sell
15,723
-197,860
-93% -$6.74M 0.1% 57
2019
Q4 		$7.94M Sell
213,583
-34,753
-14% -$1.24M 1.24% 48
2019
Q3 		$8.46M Buy
248,336
+4,340
+2% +$158K 1.39% 48
2019
Q2 		$10M Buy
243,996
+788
+0.3% +$31.3K 1.69% 36
2019
Q1 		$9.8M Buy
243,208
+236,077
+3,311% +$9.45M 1.64% 30
2018
Q4 		$295K Buy
+7,131
New +$296K 0.06% 73
2018
Q1 		– Sell
-6,318
Closed -$217K – 82
2017
Q4 		$217K Buy
6,318
+174
+3% +$5.93K 0.04% 80
2017
Q3 		$208K Sell
6,144
-1,328
-18% -$42.7K 0.04% 86
2017
Q2 		$238K Sell
7,472
-197,082
-96% -$6.22M 0.05% 84
2017
Q1 		$6.64M Buy
204,554
+16,296
+9% +$514K 1.32% 46
2016
Q4 		$5.8M Sell
188,258
-16,541
-8% -$505K 1.22% 48
2016
Q3 		$6.58M Buy
+204,799
New +$6.85M 1.39% 44
2015
Q3 		– Sell
-9,198
Closed -$292K – 111
2015
Q2 		$292K Sell
9,198
-211
-2% -$6.88K 0.03% 108
2015
Q1 		$310K Sell
9,409
-1,637
-15% -$52K 0.03% 103
2014
Q4 		$326K Sell
11,046
-1,739
-14% -$49.9K 0.03% 95
2014
Q3 		$358K Sell
12,785
-4,111
-24% -$115K 0.03% 93
2014
Q2 		$475K Sell
16,896
-285,654
-94% -$8.14M 0.04% 87
2014
Q1 		$9.22M Sell
302,550
-427,017
-59% -$12.7M 0.91% 48
2013
Q4 		$21.2M Buy
729,567
+9,821
+1% +$286K 1.98% 17
2013
Q3 		$19.6M Buy
719,746
+14,244
+2% +$388K 1.95% 14
2013
Q2 		$18.7M Buy
+705,502
New +$19.5M 1.93% 11

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

CCM Investment Advisers's PFE Position: Q4 2023 in Review

CCM Investment Advisers sold out of Pfizer (PFE) in Q4 2023, closing a stake of 6,532 shares — an estimated $217K sold.

CCM Investment Advisers first reported a position in PFE in Q2 2013 and held it in 25 quarters. The position peaked at $21.2M in Q4 2013. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • CCM Investment Advisers reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • CCM Investment Advisers sold 6,532 Pfizer shares in Q4 2023, an estimated $217K.
  • CCM Investment Advisers first reported a position in Pfizer in Q2 2013 and held it in 25 quarters.
  • CCM Investment Advisers's Pfizer position peaked at $21.2M in Q4 2013.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on CCM Investment Advisers's 13F filing for Q4 2023, filed 5 Mar 2024.